TCL Archive NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say. April 16, 2004
TCL Archive New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting January 30, 2004
TCL Archive Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal September 3, 2010
